ALK loses R&D exec, finds Novo Nordisk replacement
The allergy company has been on the hunt for a new executive vice president for research and development at the Danish pharmaceutical giant, as Henrik Jacobi announces his retirement.
by ulrich quistgaard, translated by daniel pedersen
ALK Abelló has tapped Henriette Mersebach as new executive vice president for research and development. She is expected to begin work on March 1.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
ALK CFO to step down
For subscribers
ALK raises minimum full-year sales guidance after Q3
For subscribers
